Breast cancer CTCs are classically defined as CD45–, EpCAM+, and Cytokeratin 8/18/19+ (classical CTCs or cCTCs), and this definition has yielded important insights into how CTC shedding predicts survivorship [16]. This evidence concerns the gene PTPRC and breast carcinoma.